Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on viral hepatitis in children

L N Fishman1, M M Jonas, J E Lavine

  • 1Center for Childhood Liver Disease, Children's Hospital, Boston, Massachusetts, USA.

Pediatric Clinics of North America
|February 1, 1996
PubMed
Summary

The discovery of non-A, non-B hepatitis agents has advanced viral hepatitis diagnosis and prevention. New vaccines for hepatitis A and B, plus interferon-alpha therapy for chronic hepatitis B or C, are improving patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transition experience of young adults with inflammatory bowel diseases (IBD): a mixed methods study.

Child: care, health and development·2014
Same author

Review article: the management of paediatric nonalcoholic fatty liver disease.

Alimentary pharmacology & therapeutics·2014
Same author

Multivisceral transplantation using a 2.9 kg neonatal donor.

Pediatric transplantation·2012
Same author

Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin.

Journal of viral hepatitis·2012
Same author

Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease.

Alimentary pharmacology & therapeutics·2011
Same author

Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.

Alimentary pharmacology & therapeutics·2008

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Non-A, non-B hepatitis has been a significant public health concern.
  • Advances in understanding viral agents are crucial for effective treatment and prevention.

Purpose of the Study:

  • To highlight recent progress in viral hepatitis diagnosis and prevention.
  • To discuss the impact of new therapeutic strategies.

Main Methods:

  • Discovery of major causative agents for non-A, non-B hepatitis.
  • Implementation of vaccination strategies for hepatitis A and B.
  • Application of interferon-alpha therapy for chronic hepatitis B and C.

Main Results:

  • Significant advancements in the diagnosis and prevention of viral hepatitis.
  • Successful protection of children through new vaccine strategies.
  • Eradication of disease in chronically infected patients using interferon-alpha therapy.

Conclusions:

  • The identification of key hepatitis agents has accelerated progress in managing viral hepatitis.
  • Vaccine and immunomodulatory therapies offer promising avenues for controlling hepatitis A, B, and C infections.

Related Experiment Videos